These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 28502324)
1. Favorable long-term outcomes of isolated liver transplantation in a child with atypical hemolytic uremic syndrome caused by a novel complement factor H mutation . Cho H; Lee Y Clin Nephrol; 2017 Jul; 88(1):52-56. PubMed ID: 28502324 [TBL] [Abstract][Full Text] [Related]
2. Long-term successful liver-kidney transplantation in a child with atypical hemolytic uremic syndrome caused by homozygous factor H deficiency. Gonzales E; Ulinski T; Habes D; Deschênes G; Frémeaux-Bacchi V; Bensman A Pediatr Nephrol; 2016 Dec; 31(12):2375-2378. PubMed ID: 27744619 [TBL] [Abstract][Full Text] [Related]
3. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report. Vondrák K; Seeman T Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469 [TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for aHUS: still needed in the eculizumab era? Coppo R; Bonaudo R; Peruzzi RL; Amore A; Brunati A; Romagnoli R; Salizzoni M; Galbusera M; Gotti E; Daina E; Noris M; Remuzzi G Pediatr Nephrol; 2016 May; 31(5):759-68. PubMed ID: 26604087 [TBL] [Abstract][Full Text] [Related]
5. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report. Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022 [TBL] [Abstract][Full Text] [Related]
6. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation. Tran H; Chaudhuri A; Concepcion W; Grimm PC Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349 [TBL] [Abstract][Full Text] [Related]
7. Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation. Kim S; Park E; Min SI; Yi NJ; Ha J; Ha IS; Cheong HI; Kang HG J Korean Med Sci; 2018 Jan; 33(1):e4. PubMed ID: 29215813 [TBL] [Abstract][Full Text] [Related]
8. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series. Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363 [TBL] [Abstract][Full Text] [Related]
9. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens. Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893 [TBL] [Abstract][Full Text] [Related]
10. Anti-C5 monoclonal antibody treatment showing pathological resolution of complement-mediated atypical hemolytic uremic syndrome: a case report. Kurihara S; Yamaguchi A; Sonoda K; Yamada Y; Harada M; Hashimoto K; Shimojo H; Ikeda Y; Kamijo Y BMC Nephrol; 2024 Jul; 25(1):224. PubMed ID: 39009967 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation. Ranch D; Crowther B; Arar M; Assanasen C Pediatr Transplant; 2014 Sep; 18(6):E185-9. PubMed ID: 24931815 [TBL] [Abstract][Full Text] [Related]
12. Piras R; Valoti E; Alberti M; Bresin E; Mele C; Breno M; Liguori L; Donadelli R; Rigoldi M; Benigni A; Remuzzi G; Noris M Front Immunol; 2022; 13():1011580. PubMed ID: 36793547 [TBL] [Abstract][Full Text] [Related]
13. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody. Rigothier C; Delmas Y; Roumenina LT; Contin-Bordes C; Lepreux S; Bridoux F; Goujon JM; Bachelet T; Touchard G; Frémeaux-Bacchi V; Combe C Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278 [TBL] [Abstract][Full Text] [Related]
15. Genetics and outcome of atypical hemolytic-uremic syndrome in Turkish children: a retrospective study between 2010 and 2017, a single-center experience. Conkar S; Mir S; Berdeli A Iran J Kidney Dis; 2019 Sep; 13(5):316-321. PubMed ID: 31705748 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome. Lapeyraque AL; Frémeaux-Bacchi V; Robitaille P Pediatr Nephrol; 2011 Apr; 26(4):621-4. PubMed ID: 21161283 [TBL] [Abstract][Full Text] [Related]
17. Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options. De S; Waters AM; Segal AO; Trautmann A; Harvey EA; Licht C Pediatr Nephrol; 2010 Jan; 25(1):97-104. PubMed ID: 19856002 [TBL] [Abstract][Full Text] [Related]
18. [Genetics of aHUS and transplant recurrence]. Bresin E G Ital Nefrol; 2015; 32 Suppl 64():. PubMed ID: 26479051 [TBL] [Abstract][Full Text] [Related]
19. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation. Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549 [TBL] [Abstract][Full Text] [Related]